• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Admissions to Canadian hospitals for acute asthma: a prospective, multicentre study.加拿大急性哮喘住院患者:一项前瞻性、多中心研究。
Can Respir J. 2010 Jan-Feb;17(1):25-30. doi: 10.1155/2010/178549.
2
Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments.加拿大急诊科慢性阻塞性肺疾病加重期患者住院的预测因素
Acad Emerg Med. 2009 Apr;16(4):316-24. doi: 10.1111/j.1553-2712.2009.00366.x. Epub 2009 Mar 6.
3
A prospective multicenter study of patient factors associated with hospital admission from the emergency department among children with acute asthma.一项关于急性哮喘儿童从急诊科住院相关患者因素的前瞻性多中心研究。
Arch Pediatr Adolesc Med. 2002 Sep;156(9):934-40. doi: 10.1001/archpedi.156.9.934.
4
Comparison of Canadian versus American emergency department visits for acute asthma.加拿大与美国急性哮喘急诊就诊情况的比较。
Can Respir J. 2007 Sep;14(6):331-7. doi: 10.1155/2007/450489.
5
Comparison of Canadian versus United States emergency department visits for chronic obstructive pulmonary disease exacerbation.加拿大与美国慢性阻塞性肺疾病急性加重期急诊就诊情况的比较。
Can Respir J. 2008 Sep;15(6):295-301. doi: 10.1155/2008/696482.
6
Reasons and outcomes for patients receiving ICS/LABA agents prior to, and one month after, emergency department presentations for acute asthma.急性哮喘患者在急诊科就诊前及就诊后一个月接受吸入性糖皮质激素/长效β2受体激动剂治疗的原因及结果。
J Asthma. 2019 Sep;56(9):985-994. doi: 10.1080/02770903.2018.1508472. Epub 2018 Oct 12.
7
Magnesium use in asthma pharmacotherapy: a Pediatric Emergency Research Canada study.哮喘药理学治疗中镁的应用:加拿大儿科急症研究。
Pediatrics. 2012 May;129(5):852-9. doi: 10.1542/peds.2011-2202. Epub 2012 Apr 16.
8
Rates and correlates of relapse following ED discharge for acute asthma: a Canadian 20-site prospective cohort study.急性哮喘 ED 出院后复发的发生率和相关因素:加拿大 20 个地点的前瞻性队列研究。
Chest. 2015 Jan;147(1):140-149. doi: 10.1378/chest.14-0843.
9
Relapse after emergency department discharge for acute asthma.急性哮喘患者急诊科出院后的复发情况。
Acad Emerg Med. 2008 Aug;15(8):709-17. doi: 10.1111/j.1553-2712.2008.00176.x. Epub 2008 Jul 11.
10
Inhaled magnesium sulfate in the treatment of acute asthma.吸入硫酸镁治疗急性哮喘。
Cochrane Database Syst Rev. 2012 Dec 12;12:CD003898. doi: 10.1002/14651858.CD003898.pub5.

引用本文的文献

1
Forecasting Hospitalization for Adult Asthma Patients in Emergency Departments Based on Multiple Environmental and Clinical Factors.基于多种环境和临床因素预测急诊科成年哮喘患者的住院情况
J Asthma Allergy. 2025 May 31;18:861-876. doi: 10.2147/JAA.S512405. eCollection 2025.
2
GEMA 5.3. Spanish Guideline on the Management of Asthma.GEMA 5.3. 《西班牙哮喘管理指南》。
Open Respir Arch. 2023 Sep 19;5(4):100277. doi: 10.1016/j.opresp.2023.100277. eCollection 2023 Oct-Dec.
3
Effective Asthma Management: Is It Time to Let the AIR out of SABA?有效的哮喘管理:是时候减少短效β2激动剂的使用了吗?
J Clin Med. 2020 Mar 27;9(4):921. doi: 10.3390/jcm9040921.
4
Management of severe asthma exacerbation: guidelines from the Société Française de Médecine d'Urgence, the Société de Réanimation de Langue Française and the French Group for Pediatric Intensive Care and Emergencies.重度哮喘急性加重的管理:来自法国急诊医学协会、法语国家复苏协会以及法国儿科重症监护与急诊小组的指南
Ann Intensive Care. 2019 Oct 10;9(1):115. doi: 10.1186/s13613-019-0584-x.
5
Engaging patients and primary care providers in the design of novel opinion leader based interventions for acute asthma in the emergency department: a mixed methods study.让患者和初级保健提供者参与设计基于意见领袖的急诊科急性哮喘新型干预措施:一项混合方法研究。
BMC Health Serv Res. 2018 Oct 19;18(1):789. doi: 10.1186/s12913-018-3587-7.
6
Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma.联合吸入β-激动剂和抗胆碱能药物用于成人哮喘的急救管理。
Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD001284. doi: 10.1002/14651858.CD001284.pub2.
7
Increased health service use for asthma, but decreased for COPD: Northumbrian hospital episodes, 2013-2014.2013 - 2014年诺森伯兰郡医院病例:哮喘的医疗服务使用增加,但慢性阻塞性肺疾病的使用减少。
Eur J Clin Microbiol Infect Dis. 2016 Feb;35(2):311-24. doi: 10.1007/s10096-015-2547-y. Epub 2016 Jan 15.
8
Clinical, economic, and humanistic burden of asthma in Canada: a systematic review.加拿大哮喘的临床、经济和人文负担:系统评价。
BMC Pulm Med. 2013 Dec 5;13:70. doi: 10.1186/1471-2466-13-70.
9
Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma.静脉注射β₂受体激动剂与静脉注射氨茶碱治疗急性哮喘的比较
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD010256. doi: 10.1002/14651858.CD010256.
10
Inhaled steroids for acute asthma following emergency department discharge.急诊科出院后用于急性哮喘的吸入性类固醇。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD002316. doi: 10.1002/14651858.CD002316.pub2.

本文引用的文献

1
Overdiagnosis of asthma in obese and nonobese adults.肥胖和非肥胖成年人哮喘的过度诊断
CMAJ. 2008 Nov 18;179(11):1121-31. doi: 10.1503/cmaj.081332.
2
Relapse after emergency department discharge for acute asthma.急性哮喘患者急诊科出院后的复发情况。
Acad Emerg Med. 2008 Aug;15(8):709-17. doi: 10.1111/j.1553-2712.2008.00176.x. Epub 2008 Jul 11.
3
Patients presenting to the emergency department: the use of other health care services and reasons for presentation.前往急诊科就诊的患者:其他医疗服务的使用情况及就诊原因。
CJEM. 2007 Nov;9(6):428-34. doi: 10.1017/s1481803500015451.
4
Comparison of Canadian versus American emergency department visits for acute asthma.加拿大与美国急性哮喘急诊就诊情况的比较。
Can Respir J. 2007 Sep;14(6):331-7. doi: 10.1155/2007/450489.
5
Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study.加拿大的哮喘控制情况仍未达到最佳水平:哮喘控制现状(TRAC)研究。
Can Respir J. 2006 Jul-Aug;13(5):253-9. doi: 10.1155/2006/753083.
6
The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates.安大略省哮喘区域差异研究:急诊科就诊率及其与住院率的关系。
Chest. 2006 Apr;129(4):909-17. doi: 10.1378/chest.129.4.909.
7
A prospective multicenter study of factors associated with hospital admission among adults with acute asthma.
Am J Med. 2002 Oct 1;113(5):371-8. doi: 10.1016/s0002-9343(02)01242-1.
8
Control of asthma in Canada: failure to achieve guideline targets.加拿大哮喘的控制:未达到指南目标。
Can Respir J. 2001 Mar-Apr;8 Suppl A:35A-40A. doi: 10.1155/2001/245261.
9
The health economics of asthma and rhinitis. I. Assessing the economic impact.哮喘与鼻炎的卫生经济学。I. 评估经济影响。
J Allergy Clin Immunol. 2001 Jan;107(1):3-8. doi: 10.1067/mai.2001.112262.
10
Trends in the cost of illness for asthma in the United States, 1985-1994.1985 - 1994年美国哮喘病的疾病成本趋势
J Allergy Clin Immunol. 2000 Sep;106(3):493-9. doi: 10.1067/mai.2000.109426.

加拿大急性哮喘住院患者:一项前瞻性、多中心研究。

Admissions to Canadian hospitals for acute asthma: a prospective, multicentre study.

机构信息

University of Alberta, Edmonton, Alberta, Canada.

出版信息

Can Respir J. 2010 Jan-Feb;17(1):25-30. doi: 10.1155/2010/178549.

DOI:10.1155/2010/178549
PMID:20186368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2866213/
Abstract

BACKGROUND

Asthma exacerbations constitute one of the most common causes of emergency department (ED) attendance in most developed countries. While severe asthma often requires hospitalization, variability in admission practices has been observed.

OBJECTIVE

To describe the factors associated with admission to Canadian hospitals for acute asthma after ED treatment.

METHODS

Subjects 18 to 55 years of age treated for acute asthma in 20 Canadian EDs prospectively underwent a structured ED interview (n=695) and telephone interview two weeks later.

RESULTS

The median age of the patients was 30 years, and the majority were women (62.8%). The admission rate was 13.1% (95% CI 10.7% to 15.8%). Admitted patients were older, more often receiving oral or inhaled corticosteroids at presentation, and more frequently receiving systemic corticosteroids and magnesium sulphate in the ED. Similar proportions received beta-2 agonists and/or ipratropium bromide within 1 h of arrival. On multivariable analyses, factors associated with admission included age, previous admission in the past two years, more than eight beta-2 agonist puffs in the past 24 h, a Canadian Triage and Acuity Score of 1 to 2, a respiratory rate of greater than 22 breaths/min and an oxygen saturation of less than 95%.

CONCLUSION

The admission rate for acute asthma from these Canadian EDs was lower than reported in other North American studies. The present study provides insight into practical factors associated with admission for acute asthma and highlights the importance of history and asthma severity markers on ED decision making. Further efforts to standardize ED management and expedite admission decision-making appear warranted.

摘要

背景

在大多数发达国家,哮喘加重是导致急诊科(ED)就诊的最常见原因之一。虽然严重哮喘通常需要住院治疗,但观察到入院实践存在差异。

目的

描述与加拿大 ED 治疗后因急性哮喘入院相关的因素。

方法

在 20 家加拿大 ED 接受急性哮喘治疗的 18 至 55 岁患者前瞻性接受了结构化 ED 访谈(n=695)和两周后的电话访谈。

结果

患者的中位年龄为 30 岁,大多数为女性(62.8%)。入院率为 13.1%(95%CI 10.7%至 15.8%)。入院患者年龄较大,就诊时更常接受口服或吸入皮质类固醇治疗,在 ED 中更常接受全身皮质类固醇和硫酸镁治疗。接受β-2 激动剂和/或异丙托溴铵在到达后 1 小时内的比例相似。多变量分析显示,与入院相关的因素包括年龄、过去两年内的住院史、过去 24 小时内使用超过 8 次β-2 激动剂、加拿大分诊和急症评分 1 至 2、呼吸频率大于 22 次/分钟和血氧饱和度低于 95%。

结论

这些加拿大 ED 治疗的急性哮喘入院率低于其他北美研究报告的入院率。本研究深入了解了与急性哮喘入院相关的实际因素,并强调了 ED 决策中病史和哮喘严重程度标志物的重要性。似乎有必要进一步努力标准化 ED 管理并加快入院决策。